CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
Go back to CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight| (NASDAQ: ADAG) | Delayed: 4.47 -0.31 (6.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.78 | 52 Week High | $ | |||
| Open | $4.65 | 52 Week Low | $ | |||
| Day High | $4.78 | P/E | N/A | |||
| Day Low | $4.41 | EPS | $ | |||
| Volume | 81,655 | |||||
| (NASDAQ: AUTL) | Delayed: 1.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.58 | 52 Week High | $ | |||
| Open | $1.60 | 52 Week Low | $ | |||
| Day High | $1.72 | P/E | N/A | |||
| Day Low | $1.57 | EPS | $ | |||
| Volume | 1,442,603 | |||||

